Meeting Banner
Abstract #3885

Assessment of Pathologic Complete Response of Breast Cancer with Different Molecular Subtypes after Neoadjuvant Chemotherapy with Dynamic Contrast-enhanced MR Imaging

Yuan Jiang 1 , Naishan Qin 1 , Xiaoying Wang 1 , and Li Guo 1

1 Radiology Department, Peking University First Hospital, Beijing, Beijing, China

Different molecular subtypes of breast cancer respond differently to neoadjuvant chemotherapy. Patients who achieve pathologic complete response (pCR) have better prognosis than non-pCR. In our study, semi-quantitative analysis of dynamic contrast-enhanced (DCE) MR Imaging between pCR and non-pCR was performed in four types of breast cancer (Luminal A, Luminal B, HER2+ and Triples negative), and our results showed that DCE-MR Imaging could become the potential predictor of pCR to NAC in breast cancer with Luminal B and Triples negative types. Maybe further study should be performed based on molecular subtypes of breast cancer.

This abstract and the presentation materials are available to members only; a login is required.

Join Here